United States Cold and Sinus Medications Market, 2017-2018 & 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cold
and Sinus Medications Market in the United States” report has
been added to ResearchAndMarkets.com’s offering.

A comprehensive analysis of the U.S. Cold and Sinus Medications
industry, focusing on key trends, developments, challenges, business
opportunities, and new product activity, and offers insights and
information on the following:

• Industry trends
• Market size and performance
• Brand sales and share
• Company sales and share
• New product activity
• Retail distribution
• Regulatory developments
• Rx-to-OTC switch forecasts
• Five-year historical sales
• Five-year sales forecasts

Features user-friendly database that is fully searchable and exportable
that contains sales data, growth, share, and forecasts for hundreds of
brands and companies across more than 20 categories

Contents

The data contained in this study provides information on the entire U.S.
Cold and Sinus Medications industry sales conducted through consumer
outlets for the calendar year 2017. Some sections also occasionally
cover developments for 2018 and are noted as such.

The information in the report presents a comprehensive overview
of the industry, including data on products and companies, organized for
ready reference, as follows:

• Executive Summary. This top-line summary highlights key 2017
  information and select 2018 activities and noteworthy strategic trends
  and issues.
• Products. This section gives thorough market profiles of 22 major
  product categories in 7 product classes of the industry for 2016 and
  2017.
• Major Companies. Profiled here are the principal companies with U.S.
  Cold and Sinus Medications sales exceeding $100 million, comprising
  extensive business summaries of 11 major suppliers for 2017.

Scope

This report focuses solely on products sold through domestic consumer
outlets, including those marketed via drug stores, food stores, and mass
merchandisers, in addition to non-traditional outlets, such as online,
health food stores, convenience stores, warehouse clubs, dollar stores,
and mail order, among others.

• Market data refers exclusively to sales through these outlets.
• Direct and mail order sales are included, but sales to institutions,
  such as hospitals and nursing homes, and exports are excluded.
• All market sales data are given in manufacturers’ or factory dollars,
  that is, the prices received by manufacturers before wholesale and
  retail mark-ups.
• All companies selling branded products are considered manufacturers in
  this report, regardless of whether they have manufacturing facilities
  of their own or sell products made by other companies.

The data presented in this report are believed to be
sufficiently accurate for preliminary market planning

• However, more specific and detailed studies should be conducted before
  projects that require substantial business decisions are undertaken.
• The author is pleased to assist clients on such projects through its
  custom consultation capabilities, realized through over 50 years of
  experience in consulting to the pharmaceutical industry.

Companies Mentioned

• Bayer Group
• Carlyle Group
• Church & Dwight
• GlaxoSmithKline
• Johnson & Johnson
• Perrigo Company
• Pfizer
• Prestige Brands
• Procter & Gamble
• Reckitt Benckiser
• Sanofi

For more information about this report visit https://www.researchandmarkets.com/research/dft8s2/united_states?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Cough
and Cold Drugs